Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Gossamer Bio (GOSS) Revenue: 2018-2024

Historic Revenue for Gossamer Bio (GOSS) over the last 7 years, with Dec 2024 value amounting to $90.7 million.

  • Gossamer Bio's Revenue rose 40.23% to $13.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $20.1 million, marking a year-over-year decrease of 79.74%. This contributed to the annual value of $90.7 million for FY2024, which is 771.30% up from last year.
  • As of FY2024, Gossamer Bio's Revenue stood at $90.7 million, which was up 771.30% from -$13.5 million recorded in FY2023.
  • Gossamer Bio's Revenue's 5-year high stood at $90.7 million during FY2024, with a 5-year trough of -$19.4 million in FY2021.
  • Over the past 3 years, Gossamer Bio's median Revenue value was -$13.5 million (recorded in 2023), while the average stood at $21.1 million.
  • Its Revenue has fluctuated over the past 5 years, first plummeted by 553.56% in 2020, then surged by 771.30% in 2024.
  • Over the past 5 years, Gossamer Bio's Revenue (Yearly) stood at -$12.7 million in 2020, then slumped by 53.48% to -$19.4 million in 2021, then grew by 28.60% to -$13.9 million in 2022, then grew by 2.66% to -$13.5 million in 2023, then surged by 771.30% to $90.7 million in 2024.